TSH RECEPTOR ANTIBODIES
Specimen: 5 mL blood in
plain tube.
Method: Immunoassay, cell stimulation assay.
Reference Interval: Method dependent.
Application: Limited role in diagnosis of Graves’ disease. Occasionally used
in monitoring response to treatment and to predict fetal complications in pregnant
patients. This test has superseded the insensitive LATS test.
Interpretation: Present in ³80% of patients
with Graves’ disease; disappearance with treatment is reported to be correlated with
a decreased likelihood of relapse although its predictive significance remains unclear.
Reference: Hashizume K. N Engl J Med 1991; 324: 947-953.